Menu
GeneBe

CNOT1

CCR4-NOT transcription complex subunit 1, the group of CCR4-NOT transcription complex|Small nucleolar RNA protein coding host genes|Armadillo like helical domain containing|MIF4G domain containing proteins

Basic information

Region (hg38): 16:58519950-58629885

Previous symbols: [ "NOT1" ]

Links

ENSG00000125107NCBI:23019OMIM:604917HGNC:7877Uniprot:A5YKK6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • holoprosencephaly 12 with or without pancreatic agenesis (Strong), mode of inheritance: AD
  • Vissers-Bodmer syndrome (Strong), mode of inheritance: AD
  • holoprosencephaly 12 with or without pancreatic agenesis (Moderate), mode of inheritance: AD
  • holoprosencephaly 12 with or without pancreatic agenesis (Strong), mode of inheritance: AD
  • Vissers-Bodmer syndrome (Strong), mode of inheritance: AD
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
  • holoprosencephaly 12 with or without pancreatic agenesis (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Holoprosencephaly 12, with or without pancreatic agenesisADAudiologic/Otolaryngologic; EndocrineIn addition to other findings, the condition has been described as sometimes involving congenital absence of the pancreas, which leads to medical interventions to manage early-onset insulin-dependent diabetes mellitus and the need for pancreatic enzyme replacement; In some individuals, early recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic28525974; 31006510; 32553196

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CNOT1 gene.

  • Vissers-Bodmer syndrome (3 variants)
  • Neurodevelopmental delay (2 variants)
  • Nuerodevelopment disorder (1 variants)
  • not provided (1 variants)
  • Inborn genetic diseases (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CNOT1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
96
clinvar
15
clinvar
113
missense
2
clinvar
1
clinvar
205
clinvar
11
clinvar
3
clinvar
222
nonsense
2
clinvar
2
clinvar
2
clinvar
6
start loss
0
frameshift
7
clinvar
3
clinvar
2
clinvar
2
clinvar
14
inframe indel
1
clinvar
4
clinvar
5
splice donor/acceptor (+/-2bp)
3
clinvar
2
clinvar
1
clinvar
6
splice region
1
13
21
6
41
non coding
1
clinvar
58
clinvar
70
clinvar
129
Total 7 13 218 167 90

Variants in CNOT1

This is a list of pathogenic ClinVar variants found in the CNOT1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-58520876-C-T Benign (May 10, 2021)1289270
16-58521000-C-T Likely benign (Nov 08, 2022)1974209
16-58521021-G-A Benign (Jun 29, 2023)2191274
16-58521188-G-A Likely benign (Oct 13, 2022)1973114
16-58521215-A-T Uncertain significance (Sep 04, 2023)2758049
16-58521227-C-T Likely benign (Mar 01, 2024)2065312
16-58521261-GTAA-G Uncertain significance (Mar 22, 2023)2446155
16-58521265-T-G Likely pathogenic (Dec 13, 2022)2505815
16-58521270-A-C Uncertain significance (Feb 28, 2022)1703926
16-58521271-G-C Uncertain significance (Aug 17, 2023)3253254
16-58521333-A-C Likely benign (Dec 12, 2023)2028858
16-58523305-G-GA Benign (May 10, 2021)1277952
16-58523363-C-T Likely benign (Sep 21, 2023)2070562
16-58523396-C-G Likely benign (Jun 03, 2022)2176286
16-58523434-T-C Uncertain significance (May 20, 2022)1801072
16-58523435-G-A Likely benign (Oct 13, 2022)2040651
16-58523438-G-A CNOT1-related disorder Benign (Jan 30, 2024)1569231
16-58523468-C-G Inborn genetic diseases Uncertain significance (Nov 15, 2021)2389226
16-58523496-T-G Uncertain significance (Jan 15, 2023)3017281
16-58523509-AT-A Likely benign (Nov 15, 2022)2104185
16-58525085-C-T Benign (May 10, 2021)1226579
16-58525168-G-A Benign (Jan 18, 2024)1971099
16-58525182-C-T Uncertain significance (Jun 02, 2022)2001866
16-58525248-T-A Uncertain significance (Feb 23, 2022)1703358
16-58525258-G-A Likely benign (Oct 17, 2022)2107828

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CNOT1protein_codingprotein_codingENST00000317147 48109936
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.004.56e-20125740041257440.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense7.255611.30e+30.4330.000069115670
Missense in Polyphen51290.680.175453560
Synonymous-0.5144704561.030.00002404564
Loss of Function10.311250.008000.000006811440

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.00005460.0000544
Finnish0.000.00
European (Non-Finnish)0.00002640.0000176
Middle Eastern0.00005460.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Scaffolding component of the CCR4-NOT complex which is one of the major cellular mRNA deadenylases and is linked to various cellular processes including bulk mRNA degradation, miRNA- mediated repression, translational repression during translational initiation and general transcription regulation. Additional complex functions may be a consequence of its influence on mRNA expression. Its scaffolding function implies its interaction with the catalytic complex module and diverse RNA-binding proteins mediating the complex recruitment to selected mRNA 3'UTRs. Involved in degradation of AU-rich element (ARE)-containing mRNAs probably via association with ZFP36. Mediates the recruitment of the CCR4-NOT complex to miRNA targets and to the RISC complex via association with TNRC6A, TNRC6B or TNRC6C. Acts as a transcriptional repressor. Represses the ligand-dependent transcriptional activation by nuclear receptors. Involved in the maintenance of emryonic stem (ES) cell identity. {ECO:0000269|PubMed:10637334, ECO:0000269|PubMed:16778766, ECO:0000269|PubMed:21278420, ECO:0000269|PubMed:21976065, ECO:0000269|PubMed:21984185, ECO:0000269|PubMed:22367759, ECO:0000269|PubMed:23644599}.;
Pathway
RNA degradation - Homo sapiens (human);Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Metabolism of RNA;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;TP53 Regulates Transcription of Cell Cycle Genes;Transcriptional Regulation by TP53;Deadenylation of mRNA;Deadenylation-dependent mRNA decay (Consensus)

Recessive Scores

pRec
0.135

Intolerance Scores

loftool
0.191
rvis_EVS
-1.9
rvis_percentile_EVS
1.97

Haploinsufficiency Scores

pHI
0.468
hipred
Y
hipred_score
0.783
ghis
0.679

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.927

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cnot1
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype;

Zebrafish Information Network

Gene name
cnot1
Affected structure
anatomical system
Phenotype tag
abnormal
Phenotype quality
quality

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;nuclear-transcribed mRNA poly(A) tail shortening;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;multicellular organism development;positive regulation of cytoplasmic mRNA processing body assembly;negative regulation of translation;negative regulation of intracellular estrogen receptor signaling pathway;gene silencing by miRNA;negative regulation of retinoic acid receptor signaling pathway;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of mRNA catabolic process;RNA phosphodiester bond hydrolysis, exonucleolytic;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;regulation of stem cell population maintenance
Cellular component
P-body;extracellular space;nucleus;cytosol;membrane;CCR4-NOT complex
Molecular function
RNA binding;poly(A)-specific ribonuclease activity;protein binding;protein domain specific binding;estrogen receptor binding;protein-containing complex scaffold activity;retinoic acid receptor binding;armadillo repeat domain binding